Non-enrolment of ovarian cancer patients in clinical trials: reasons and background-Reference-Cited by-同舟云学术

Non-enrolment of ovarian cancer patients in clinical trials: reasons and background

Published:2005-11 Issue:11 Volume:16 Page:1801-1805
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Harter P.,du Bois A.,Schade-Brittinger C.,Burges A.,Wollschlaeger K.,Gropp M.,Schmalfeldt B.,Huober J.,Staehle A.,Pfisterer J.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/16/11/1801/302873/mdi367.pdf

Reference31 articles.

1. Factors that influence the recruitment of patients to phase III studies in oncology;Wright;Cancer,2002

2. Barriers to participation in randomized controlled trials: a systematic review;Ross;J Clin Epidemiol,1999

3. Altmann DG for the CONSORT Group. The CONSORT statement: revise recommendations for improving the quality of reports of parallel-group randomised trials;Moher;Lancet,2001

4. on Behalf of the Austrian Breast & Colorectal Cancer Study Group. Impact of participation in randomized clinical trials on survival of women with early stage breast cancer;Gnant;Proc Am Soc Clin Oncol,2000

5. Die Therapie des fortgeschrittenen Ovarialkarzinoms in Deutschland: Welchen Einfluss hat die Teilnahme an klinischen Studien;du Bois;Geburtsh Frauenheilkd,2001

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ovarian cancer in the older patient: where are we now? What to do next?;Therapeutic Advances in Medical Oncology;2023-01

2. Multi-Disciplinary Care Planning of Ovarian Cancer in Older Patients: General Statement—A Position Paper from SOFOG-GINECO-FRANCOGYN-SFPO;Cancers;2022-03-02

3. Validation of the geriatric vulnerability score in older patients with ovarian cancer: an analysis from the GCIG-ENGOT-GINECO EWOC-1 study;The Lancet Healthy Longevity;2022-03

4. European Society of Gynaecological Oncology quality indicators for the surgical treatment of endometrial carcinoma;International Journal of Gynecologic Cancer;2021-11-18

5. Early treatment modifications improve chemotherapy adherence in ovarian cancer patients ≥70 years;Gynecologic Oncology;2019-06